Sunday, June 13, 2021
Home Venture Capital

Venture Capital

Bayer Acquires Noria and PSMA Therapeutics to Expand Pipeline in Prostate Cancer

WHIPPANY, N.J.-- Bayer today announced that it has entered into an agreement to acquire Noria Therapeutics Inc. (Noria) and PSMA Therapeutics Inc. Through this...

Blackstone Has Acquired Desotec

CHICAGO-- Lincoln International, a global investment banking advisory firm, has advised Blackstone on the acquisition of Desotec. Based in Roeselare, Belgium, Desotec’s mission is to...

Nayya Raises $37 Million in Series B Growth Capital, co-led by SVB Capital and ICONIQ Growth

NEW YORK-- Nayya, a leading insurance benefits experience and healthcare management platform, today announced that it has raised $37M in Series B financing, co-led...

Oxford Finance Provides $24 Million Credit Facility to Lantern Group

ALEXANDRIA, Va. -- Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, today...

Solesis Completes Investment from Altaris Capital Partners

TELFORD, Pa.-- Solesis LLC (“Solesis” or the “Company”), the healthcare subsidiary of Compagnie Generale des Etablissements Michelin SCA (“Michelin”), announced today that Altaris Capital...

Accelerator Life Science Partners’ Portfolio Company Lodo Therapeutics Acquired by Zymergen Inc.

SEATTLE-- Accelerator Life Science Partners (“ALSP”), a leading early-stage life science accelerator and investment firm, today announced that its portfolio company, Lodo Therapeutics Corporation...

Vetster Raises $12.25M CAD to Revolutionize Global Pet Care Industry

TORONTO-- Vetster, the world’s first comprehensive virtual veterinary and pet care marketplace, today announced it has raised a total of $12.25M CAD after only...

Smart Eye Acquires Affectiva to Solidify Stronghold on Interior Sensing Market

GOTHENBURG, Sweden & BOSTON-- Today, Smart Eye and Affectiva announced that they have entered into an agreement in which Smart Eye will acquire Affectiva...

Torus Biosystems Announces $25 Million Series A Financing to Advance Infectious Disease Diagnostics Across Healthcare Settings

CAMBRIDGE, Mass.-- Torus Biosystems, a company pioneering the future of infectious disease diagnostics, today announced the completion of a $25 million Series A financing....

Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences

BEDFORD, Mass.-- Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions...

Giiant Pharma Inc Announced the Closing of US$11m in Seed Financing to Develop Its Precision Delivery Technology Platform in Gastroenterology

MONTREAL-- Giiant Pharma inc., a Montreal-based preclinical-stage biotech company, today announced the closing of US$11M (CAD$ 13.5M) million in Seed financing. The round was...

Numab Therapeutics Completes Oversubscribed CHF 100 Million Series C Financing

WAEDENSWIL, Switzerland-- Numab Therapeutics AG, a clinical stage biopharmaceutical company developing next-generation multispecific antibody-based immunotherapies for cancer and inflammation, today announced the closing of...
- Advertisment -

Most Read